Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study

Detalles Bibliográficos
Autores principales: Amin, Asim, Plimack, Elizabeth R., Ernstoff, Marc S., Lewis, Lionel D., Bauer, Todd M., McDermott, David F., Carducci, Michael, Kollmannsberger, Christian, Rini, Brian I., Heng, Daniel Y. C., Knox, Jennifer, Voss, Martin H., Spratlin, Jennifer, Berghorn, Elmer, Yang, Lingfeng, Hammers, Hans J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416882/
https://www.ncbi.nlm.nih.gov/pubmed/30871617
http://dx.doi.org/10.1186/s40425-019-0559-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416882/
https://www.ncbi.nlm.nih.gov/pubmed/30871617
http://dx.doi.org/10.1186/s40425-019-0559-3

Ejemplares similares